StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd

TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$21.77+0.36 (+1.68%)

Close on Nov 20, 2026Market cap $75.03BP/E –Yield –

Takeda Pharmaceutical Net Debt (IFRS Book Value Basis) by Quarter

Periods

Takeda Pharmaceutical Net Debt (IFRS Book Value Basis): -4,157.10 JPY billion in Q2 FY27, up 4.9% from a year earlier.

Latest, Q2 FY27
-4,157.10
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
+4.9%
-3,963.80 in Q2 FY26
History
11 quarters
Since Q4 FY24
Sources
10
Documents cited below

Where the Q2 FY27 figure comes from

“|| Net Debt *1 | (4,157.1) | Acquisition of intangible assets | (39.9) | (60.5)”

Source: SEC EDGAR Filing (exhibit991_102926.htm) ↗

Reported in Form 6-K Exhibit 99.1 Quarterly Financial Appendix.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Debt (IFRS Book Value Basis)Year on yearSource
Q2 FY27CQ3 2026Sep 30, 2026-4,157.10+4.9%SEC EDGAR Filing (exhibit991_102926.htm) ↗
Q1 FY27CQ2 2026Jun 30, 2026-4,479.00+7.8%SEC EDGAR Filing (exhibit991_073026.htm) ↗
Q4 FY26CQ1 2026Mar 31, 2026-4,286.80+3.8%SEC EDGAR Filing (exhibit991_051326.htm) ↗
Q3 FY26CQ4 2025Dec 31, 2025-4,198.40-3.4%SEC EDGAR Filing (exhibit991_012926.htm) ↗
Q2 FY26CQ3 2025Sep 30, 2025-3,963.80-5.4%SEC EDGAR Filing (exhibit991_103025.htm) ↗
Q1 FY26CQ2 2025Jun 30, 2025-4,155.90-11.1%SEC EDGAR Filing (exhibit991_073025.htm) ↗
Q4 FY25CQ1 2025Mar 31, 2025-4,130.20-5.8%SEC EDGAR Filing (exhibit991_050825.htm) ↗
Q3 FY25CQ4 2024Dec 31, 2024-4,346.00–SEC EDGAR Filing (exhibit991_013025.htm) ↗
Q2 FY25CQ3 2024Sep 30, 2024-4,192.20–SEC EDGAR Filing (exhibit991_103124.htm) ↗
Q1 FY25CQ2 2024Jun 30, 2024-4,676.70–SEC EDGAR Filing (exhibit991_073124.htm) ↗
Q4 FY24CQ1 2024Mar 31, 2024-4,386.00–SEC EDGAR Filing (exhibit991_073124.htm) ↗

Cite this data

StockData. (2026). Takeda Pharmaceutical Net Debt (IFRS Book Value Basis), quarterly Q4 FY24–Q2 FY27 [Data set]. Compiled from Takeda Pharmaceutical SEC filings and investor materials. https://stockdatahq.com/stocks/tak/kpis/sec-net-debt

See every metric in the Takeda Pharmaceutical KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?